Toggle navigation
About Bio-Path
Leadership Team
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Prexigebersen
BP1002
BP1003
Investors
Analyst Coverage
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
Presentations & Publications
Press Releases
Events
Presentations & Publications
Recent Presentations & Publications
Webcast Link to 2021 Third Quarter Earnings Financial Results Conference Call - Friday, November 12, 2021 at 8:30 a.m. ET
Webcast Link to 2021 Second Quarter Earnings Financial Results Conference Call – Friday, August 13, 2021 at 8:30 a.m. ET
Webcast Link to 2021 First Quarter Earnings Financial Results Conference Call – Friday, May 14, 2021 at 8:30 a.m. ET
Corporate Presentation March 2021
Webcast Link to 2020 Year End Earnings 2020 Financial Results Conference Call – Wednesday, March 10, 2021 at 8:30 a.m. ET
Annual Shareholders Presentation Slides - December 2020
Webcast Link to Third Quarter 2020 Financial Results Conference Call - Friday November 13, 2020 @ 8:30 a.m. ET
Corporate Presentation September 2020
Webcast Link to Second Quarter 2020 Financial Results Conference Call - Friday, August 14, 2020 at 8:30 a.m. ET
STONEGATE Capital Partners December 4, 2019 Report
H.C. Wainwright / BPTH: Safety Testing of Phase 2 AML Trial Completed; Financing Closed; Reiterate Buy; Adjusting PT to $25
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) – January 2019
Stonegate Capital Partners Research Report - August 2018
BP1001 phase I-Ib protocol
Drug Development and Delivery Published Article: DNA THERAPEUTICS - DNAbilize-ING Antisense
Published Article: Evolution of Antisense Oligonucleotides in Oncology
Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01
OncLive interview with Dr. Cortes on BP-100.01 in Patients with Relapsed/Refractory AML
Bio-Path Hopes to Blaze Profitable Path With Antisense Drugs - January 2016
Events
View Our Events
Press Releases
View Our Press Releases
Delivering a Better Path for Cancer Patients.